Product NDC: | 10337-477 |
Proprietary Name: | Tyzine Pediatric |
Non Proprietary Name: | TETRAHYDROZOLINE HYDROCHLORIDE |
Active Ingredient(s): | .5 mg/mL & nbsp; TETRAHYDROZOLINE HYDROCHLORIDE |
Administration Route(s): | NASAL |
Dosage Form(s): | SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 10337-477 |
Labeler Name: | PharmaDerm A division of Fougera Pharmaceuticals Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA086576 |
Marketing Category: | ANDA |
Start Marketing Date: | 19791130 |
Package NDC: | 10337-477-15 |
Package Description: | 15 mL in 1 BOTTLE, DROPPER (10337-477-15) |
NDC Code | 10337-477-15 |
Proprietary Name | Tyzine Pediatric |
Package Description | 15 mL in 1 BOTTLE, DROPPER (10337-477-15) |
Product NDC | 10337-477 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | TETRAHYDROZOLINE HYDROCHLORIDE |
Dosage Form Name | SOLUTION |
Route Name | NASAL |
Start Marketing Date | 19791130 |
Marketing Category Name | ANDA |
Labeler Name | PharmaDerm A division of Fougera Pharmaceuticals Inc. |
Substance Name | TETRAHYDROZOLINE HYDROCHLORIDE |
Strength Number | .5 |
Strength Unit | mg/mL |
Pharmaceutical Classes |